Moneylet.com where you decide financial news!
Moneylet.com where you decide financial news!
Credits
Financial Stocks: Financials end rocky day with foothold in black
robert 63 days ago (via feeds.marketwatch.com)
Shares of leading U.S. financial companies reclaim positive territory at the close after having been whipsawed along with the broader market.
0 Comments - More Info - Bury Topic: Banking
Credits
MarketWatch First Take: Doubts don't hamper the biggest IPO ever
robert 63 days ago (via feeds.marketwatch.com)
Agricultural Bank of China Ltd. showed Tuesday there are still investors who believe in the emerging market’s banking system, writes David Weidner.n
5 Comments - More Info - Bury Topic: Banking
Credits
Currencies: Dollar touches 2-month lows then recovers some
robert 63 days ago (via feeds.marketwatch.com)
The dollar pares losses after trading near a two-month low against the euro after U.S. stocks give up notable gains notched earlier in the session.
0 Comments - More Info - Bury Topic: Banking
Credits
Corrections: Will Q2 GDP growth be weaker than expected
robert 63 days ago (via feeds.marketwatch.com)
On July 2, a MarketWatch preview on economic indicators cited an incorrect forecast for Bernard Baumohl, chief global economist at The Economic Outlook Group. Baumohl expects the gross domestic product will increase at a 3.8% annual rate in the second quarter.
0 Comments - More Info - Bury Topic: Banking
Credits
The ASCO Weekend Live Blog Recap
robert 63 days ago (via thestreet.com)
Highlights from Adam Feuerstein's live coverage of the ASCO annual meeting Saturday and Sunday.
0 Comments - More Info - Bury Topic: Biotech
Credits
Biotech Stock Mailbag: ASCO
robert 63 days ago (via thestreet.com)
Adam Feuerstein answers readers' questions about health care- and drug-related companies.
1 Comments - More Info - Bury Topic: Biotech
Credits
Past Sequenom Exec Charged with Lying by SEC
robert 63 days ago (via thestreet.com)
Sequenom's R&D chief manipulated and lied about data pertaining to company's gene test for Down's syndrome, alleges SEC.
0 Comments - More Info - Bury Topic: Biotech
Credits
Celgene Acquires Abraxis for $2.9 Billion
robert 63 days ago (via thestreet.com)
Celgene's purchase expands the company into the solid tumor cancer drug market.
0 Comments - More Info - Bury Topic: Biotech
Credits
ASCO Live Blog: Sunday
robert 63 days ago (via thestreet.com)
Here are the highlights from the second full day of clinical data presentations at ASCO 2010.
0 Comments - More Info - Bury Topic: Biotech
Credits
Safe haven from the tax storm
robert 63 days ago (via feeds.marketwatch.com)
It’s easy to see why so many companies from a variety of different sectors choose to base themselves in Switzerland, which is well known for its home-grown financial and pharmaceutical industries. But there are some clouds on the horizon, according to Agene Smith.n
0 Comments - More Info - Bury Topic: Banking